These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11680148)

  • 1. [Keep medical education independent! It should not be a scene of drug industry marketing].
    Eliasson G; Håkansson J
    Lakartidningen; 2001 Sep; 98(39):4168-9. PubMed ID: 11680148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug indoctrination or education? You are member of the county council's political committee].
    Andrén-Sandberg A
    Lakartidningen; 2003 Oct; 100(42):3328-32. PubMed ID: 14619046
    [No Abstract]   [Full Text] [Related]  

  • 3. When doctors go to class, industry often foots the bill: lectures tend to feature pills made by course sponsors; companies deny influence; a purple heartburn brochure.
    Hensley S
    Wall St J (East Ed); 2002 Dec; ():A1, A12. PubMed ID: 12653117
    [No Abstract]   [Full Text] [Related]  

  • 4. Beyond the naïve "no-see": ethical prescribing and the drive for pharmaceutical transparency.
    Oldani M
    PM R; 2009 Jan; 1(1):82-6. PubMed ID: 19627878
    [No Abstract]   [Full Text] [Related]  

  • 5. Industry spending on continuing medical education in US falls further.
    Roehr B
    BMJ; 2012 Aug; 345():e5336. PubMed ID: 22872716
    [No Abstract]   [Full Text] [Related]  

  • 6. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationships between family physicians and the pharmaceutical industry.
    Ostergaard DJ
    J Fam Pract; 1992 Jan; 34(1):29-31. PubMed ID: 1728650
    [No Abstract]   [Full Text] [Related]  

  • 8. Finding the line: physicians, pharma, and drug development.
    Redig A
    Acad Med; 2009 Feb; 84(2):228-9. PubMed ID: 19174673
    [No Abstract]   [Full Text] [Related]  

  • 9. [Views on marketing of a neuroleptic agent].
    Bendz H
    Lakartidningen; 1999 Nov; 96(47):5191-2. PubMed ID: 10608107
    [No Abstract]   [Full Text] [Related]  

  • 10. Educating ourselves.
    Potdar RD
    Indian Pediatr; 2000 Nov; 37(11):1287-8. PubMed ID: 11086325
    [No Abstract]   [Full Text] [Related]  

  • 11. Ties that bind? The web of CME and medical industry profit.
    Busby J
    Tex Med; 1991 Aug; 87(8):38-46. PubMed ID: 1925989
    [No Abstract]   [Full Text] [Related]  

  • 12. [Commercialization of the medical research is a reality. What is the limit?].
    Naeser K
    Ugeskr Laeger; 2005 Oct; 167(43):4103; author reply 4103-5. PubMed ID: 16251105
    [No Abstract]   [Full Text] [Related]  

  • 13. [When will we see "Physicians without sponsors" in Sweden?].
    Lindberg M
    Lakartidningen; 2005 Jun 6-12; 102(23):1830. PubMed ID: 15997555
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rules of the game in drug marketing].
    Palva E
    Duodecim; 1999; 115(20):2187, 2189. PubMed ID: 11973920
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of industry in Internet education.
    Wieting MW; Mevis H; Zuckerman JD
    Clin Orthop Relat Res; 2003 Jul; (412):28-32. PubMed ID: 12838048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dependence on the industry must be abolished: the medical profession should see that employers take responsibility for continuing education of their employees].
    Werkö L
    Lakartidningen; 2004 Mar; 101(10):925-8; discussion 929. PubMed ID: 15055058
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmaceutical industry and the medical profession.
    Phatak A
    Issues Med Ethics; 1998; 6(4):131-2. PubMed ID: 16267942
    [No Abstract]   [Full Text] [Related]  

  • 18. [Marketing of researchers--lack of judgment or a new trend?].
    Werkö L; Hernborg A; Liedholm H; Melander A
    Lakartidningen; 2002 Apr; 99(17):1962-3. PubMed ID: 12043423
    [No Abstract]   [Full Text] [Related]  

  • 19. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 20. [Marketing of the LIFE trial anticipates evaluation of the drug].
    Järhult B
    Lakartidningen; 2002 Apr; 99(17):1964. PubMed ID: 12043424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.